Adicet Bio (ACET) Interest & Investment Income (2018 - 2026)

Adicet Bio's Interest & Investment Income history runs 9 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• In Q1 2026, Interest & Investment Income fell 20.26% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $5.4 million (down 42.65% YoY), while the FY2025 annual figure was $5.8 million, down 46.08% from the prior year.
• Interest & Investment Income for Q1 2026 stood at $1.3 million, down from $1.5 million in the prior quarter.
• The five-year high for Interest & Investment Income was $3.0 million in Q2 2024, with the low at $32000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $2.1 million (2024), against an average of $1.9 million.
• The sharpest annual moves came in 2022 and 2025: Interest & Investment Income jumped 30500.0% in 2022, then tumbled 57.07% in 2025.
• Adicet Bio's Interest & Investment Income stood at $2.2 million in 2022, then fell by 0.05% to $2.2 million in 2023, then decreased by 5.1% to $2.1 million in 2024, then retreated by 26.27% to $1.5 million in 2025, then retreated by 11.94% to $1.3 million in 2026.
• Business Quant data shows ACET's Interest & Investment Income at $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $1.2 million in Q3 2025.